AIDS. Human immunodeficiency virus [HIV] disease
Conditions
Interventions
Intervention 1: Intervention group: patients underwent IMOD infusion in addition to HAART therapy.
IMOD vials contain 120 mg in 4 cc. It was diluted in 50 to 100 ml of 5% dextrose and administrated wi
Treatment - Drugs
Control group: The HAART regimen that includes 1 NNRTI + 2 NRTI.
*nucleoside reverse transcriptase inhibitors (NRTIs)
**non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Intervention group: patients underwent IMOD infusion in addition to HAART therapy.
IMOD vials contain 120 mg in 4 cc. It was diluted in 50 to 100 ml of 5% dextrose and administrated within half an ho
Sponsors
Vice chancellor for research Of Qom Branch Of Islamic Azad University - Counseling Center for Behavi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: HIV-positive patients (with two positive ELISA tests and a positive Western blot test) with Indications for treatment with HAART regimen Exclusion criteria: The patient withdrew from the study of cooperation
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CD4 (cluster of differentiation 4). Timepoint: Before and after the interventions(After 90 days). Method of measurement: Flow cytometry.;TLC ( Total lymphocyte count ). Timepoint: Before and after the interventions(After 90 days). Method of measurement: CBC Diff. | — |
Secondary
| Measure | Time frame |
|---|---|
| BUN , Cr. Timepoint: Before and after the interventions(After 90 days). Method of measurement: Routine laboratory scale measurements.;Liver function tests (LFT). Timepoint: Before and after the interventions(After 90 days). Method of measurement: Routine laboratory scale measurements. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Gholamzadeh Baees
Qom Branch Of Islamic Azad University
Outcome results
None listed